(Q43997713)

28 November 2017

title

Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

K Ashley Milton

1

1 reference

28 November 2017

Nicholas R Scott

2

1 reference

28 November 2017

Michael J Allen

3

1 reference

28 November 2017

Samantha Abel

4

1 reference

28 November 2017

Vivienne C Jenkins

5

1 reference

28 November 2017

Gerry C James

6

1 reference

28 November 2017

David J Rance

7

1 reference

28 November 2017

Malcolm D Eve

8

1 reference

28 November 2017

language of work or name

1 reference

1 May 2002

1 reference

The Journal of Clinical Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

42

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

528-539

1 reference

Epidemiology of headache in a general population--a prevalence study.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

A study of migraine and its effects in a working population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Determination of eletriptan in plasma and saliva using automated sequential trace enrichment of dialysate and high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Oral sumatriptan in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Influence of a 5HT1 receptor agonist on gastric accommodation and initial transpyloric flow in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011580

10.1177/00912700222011580

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference